FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What is Mohs micrographic surgery? 8 FAQs about Mohs

2.

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

3.

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

4.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

5.

The Kansas Cancer Center awarded two Indian American doctors professorships.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot